Premium
Quantitation of small molecules using high‐resolution accurate mass spectrometers – a different approach for analysis of biological samples
Author(s) -
Zhang Nanyan Rena,
Yu Sean,
Tiller Philip,
Yeh Suzie,
Mahan Elizabeth,
Emary William Bart
Publication year - 2009
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.3975
Subject(s) - chemistry , orbitrap , mass spectrometry , analyte , triple quadrupole mass spectrometer , resolution (logic) , chromatography , linearity , selected reaction monitoring , analytical chemistry (journal) , ion trap , quadrupole ion trap , tandem mass spectrometry , hybrid mass spectrometer , physics , quantum mechanics , artificial intelligence , computer science
The quantitative capabilities of a linear ion trap high‐resolution mass spectrometer (LTQ‐Orbitrap™) were investigated using full scan mode bracketing the m/z range of the ions of interest and utilizing a mass resolution (mass/FWHM) of 15000. Extracted ion chromatograms using a mass window of ±5–10 mmu centering on the theoretical m/z of each analyte were generated and used for quantitation. The quantitative performance of the LTQ‐Orbitrap™ was compared with that of a triple quadrupole (API 4000) operating using selected reaction monitoring (SRM) detection. Comparable assay precision, accuracy, linearity and sensitivity were observed for both approaches. The concentrations of actual study samples from 15 Merck drug candidates reported by the two methods were statistically equivalent. Unlike SRM being a tandem mass spectrometric (MS/MS)‐based detection method, a high resolution mass spectrometer operated in full scan does not need MS/MS optimization. This approach not only provides quantitative results for compounds of interest, but also will afford data on other analytes present in the sample. An example of the identification of a major circulating metabolite for a preclinical development study is demonstrated. Copyright © 2009 John Wiley & Sons, Ltd.